ArticleDiabetology international2020

Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes.

Hitomi Komatsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.